ArticleLifetime data analysis2026
Gradient boosting machine for survival prediction in studies with general failure-time outcome-dependent sampling design.
Article in Lifetime data analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Outcome-dependent sampling (ODS) designs are widely used in epidemiological and biomedical research as cost-effective alternatives to full cohort studies. While existing research has focused on parameter estimation and inference under specific models, survival prediction in ODS settings remains underexplored. In this paper, we propose a gradient boosting machine tailored for survival prediction in studies conducted using general failure-time ODS designs. Our approach integrates a weighting scheme to correct for sampling bias and improves predictive accuracy. We introduce a weighted empirical risk based on the integrated Brier score for hyperparameter tuning and establish its convergence to the corresponding integrated Brier-score risk. The proposed method is evaluated through extensive simulations and applied to the Cancer Incidence and Mortality of Uranium Miners Study, and is shown to have improved effectiveness in survival prediction. This work advances machine learning methods for ODS studies, offering valuable insights for personalized medicine and clinical decision-making in failure-time ODS settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.